113 results on '"Barkan GA"'
Search Results
2. A prospective evaluation of the prostate microbiome in malignant and benign tissue using transperineal biopsy.
- Author
-
Chen VS, James C, Khemmani M, Desai S, Doshi C, Rac G, Ellis JL, Patel HD, Barkan GA, Gupta GN, Flanigan RC, and Wolfe AJ
- Subjects
- Humans, Male, Prospective Studies, Middle Aged, Aged, Magnetic Resonance Imaging methods, Biopsy methods, Image-Guided Biopsy methods, RNA, Ribosomal, 16S analysis, RNA, Ribosomal, 16S genetics, Prostatic Neoplasms pathology, Prostatic Neoplasms microbiology, Prostate pathology, Prostate microbiology, Prostate diagnostic imaging, Perineum microbiology, Perineum pathology, Microbiota
- Abstract
Background: The link between the prostate microbiome and prostate cancer remains unclear. Few studies have analyzed the microbiota of prostate tissue, and these have been limited by potential contamination by transrectal biopsy. Transperineal prostate biopsy offers an alternative and avoids fecal cross-contamination. We aim to characterize the prostate microbiome using transperineal biopsy., Methods: Patients with clinical suspicion for prostate cancer who were to undergo transperineal prostate biopsy with magnetic resonance imaging (MRI) fusion guidance were prospectively enrolled from 2022 to 2023. Patients were excluded if they had Prostate Imaging Reporting and Data System lesions with scores ≤ 3, a history of prostate biopsy within 1 year, a history of prostate cancer, or antibiotic use within 30 days of biopsy. Tissue was collected from the MRI target lesions and nonneoplastic transitional zone. Bacteria were identified using 16S ribosomal RNA gene sequencing., Results: Across the 42 patients, 76% were found to have prostate cancer. Beta diversity indices differed significantly between the perineum, voided urine, and prostate tissue. There were no beta diversity differences between cancerous or benign tissue, or between pre- and postbiopsy urines. There appear to be unique genera more abundant in cancerous versus benign tissue. There were no differences in alpha diversity indices relative to clinical findings including cancer status, grade, and risk group., Conclusions: We demonstrate a rigorous method to better characterize the prostate microbiome using transperineal biopsy and to limit contamination. These findings provide a framework for future large-scale studies of the microbiome of prostate cancer., (© 2024 Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF
3. Cytologic-Histologic Correlation Practices for Nongynecologic Cytology Specimens: A Survey by the College of American Pathologists Cytopathology Committee.
- Author
-
Nguyen LN, Crothers BA, Souers RJ, Barkan GA, Brainard J, Nassar A, Rollins S, Tabatabai ZL, Tabbara S, Witt B, and Booth CN
- Subjects
- Humans, United States, Surveys and Questionnaires, Societies, Medical, Female, Practice Patterns, Physicians' statistics & numerical data, Practice Patterns, Physicians' standards, Cytology, Cytodiagnosis methods, Pathology, Clinical standards, Pathologists
- Abstract
Context.—: Cytologic-histologic correlation (CHC) is a Clinical Laboratory Improvement Amendments-mandated requirement for gynecologic cytology, but no similar requirement exists for nongynecologic cytology. This study presents the findings from a College of American Pathologists survey of nongynecologic cytology practice patterns., Objective.—: To survey the current CHC practices for nongynecologic cytology., Design.—: Data were analyzed from a survey developed by the committee and distributed to participants in the Nongynecologic Cytopathology Education Program mailing., Results.—: Adoption of CHC for nongynecologic cytology cases is worldwide, with 88.5% of institutions performing CHC on these specimens, a substantial increase from previous years. Performance of CHC varied by institution type, with clinic or regional/local independent laboratories and national/corporate laboratories performing CHC significantly less frequently than hospitals, university hospitals/academic medical centers, and Veterans Administration/Department of Defense hospital institutions. Most CHC was performed concurrently in real time, when the corresponding surgical specimen was reviewed. Selection for real-time concurrent CHC was by the interpreting pathologist, the pathologist diagnosing the surgical biopsy sample or cytopathology case, or both. Sampling was by far the most common reason for discordance. A 2-step difference was the most frequent threshold for discordance between cytology and surgical specimens, but this criterion varied among institutions, with no majority definition. The positive predictive value of a positive cytology finding was calculated rarely in North American institutions but was calculated more frequently in international institutions., Conclusions.—: CHC practices for nongynecologic cytopathology mirror those found for CHC of gynecologic cytopathology., (© 2024 College of American Pathologists.)
- Published
- 2024
- Full Text
- View/download PDF
4. A systematic review on performance characteristics of FNA of renal lesions: It is time for a standardized classification system.
- Author
-
Katipoglu K, Kilic I, Kurtulan O, Akdas Y, and Barkan GA
- Subjects
- Humans, Biopsy, Fine-Needle, Cytodiagnosis methods, Cytodiagnosis standards, Kidney Neoplasms pathology, Kidney Neoplasms classification, Kidney Neoplasms diagnosis
- Abstract
Background: The incidence of renal tumors has steadily increased over the past decade. In this study, the authors performed a systematic review and analysis of the literature on renal fine-needle aspiration (FNA) to determine its performance and explore whether a standardized classification system can be used for reporting renal FNA cytology., Methods: A systematic search of published articles on renal FNA was conducted. The data on FNA and histologic diagnosis were extracted and categorized, and the risk of malignancy was calculated. Different scenarios were used to estimate FNA performance statistics., Results: Of the 3766 potentially relevant studies, 23 met the inclusion criteria of the study. The 2231 FNA cases included were re-categorized according to the classification system, rendering 142 (6.36%) nondiagnostic, 270 (12.1%) nonneoplastic, 271 (12.14%) benign neoplasm, 65 (2.91%) renal neoplasm with unknown malignant potential, oncocytic type, 25 (1.12%) atypia of undetermined significance, 60 (2.68%) suspicious for malignancy, and 1398 (62.66%) malignant FNA diagnoses. The risk of malignancy in these cases was 65.4%, 18.1%, 16.6%, 16.9%, 60%, 73.3%, and 96.9%, respectively. According to the classification system, the study indicated that the accuracy of renal FNA was between 91% and 95%, the sensitivity was 90.9%-96.7%, and the specificity was 82%-92% in different scenarios., Conclusions: There is a need for a standardized reporting in renal cytology that will improve the sensitivity and accuracy of renal cytology, reduce the rate of indeterminate diagnoses, and alter the management strategies of renal lesions. Based on the available literature, a new reporting system is proposed, including categories with an associated risk of malignancy., (© 2024 American Cancer Society.)
- Published
- 2024
- Full Text
- View/download PDF
5. Evaluation and application of American College of Radiology Thyroid Imaging Reporting and Data System for improved malignancy detection in paediatric thyroid nodules.
- Author
-
Ortega CA, Gallant JN, Kilic I, Patel S, Chen SC, Wood CB, Adams R, Azer F, Wang H, Liang J, Duffus SH, Belcher RH, Andreotti RF, Krishnasarma R, Lim-Dunham JE, Barkan GA, Ye F, and Weiss VL
- Abstract
Objective: The American College of Radiology Thyroid Imaging Reporting and Data System (TI-RADS) is a widely used method for the management of adult thyroid nodules. However, its use in paediatric patients is controversial because adult fine needle aspiration biopsy (FNAB) recommendations may lead to delayed diagnoses of cancer in children. The objectives of this study were to evaluate the performance of TI-RADS in paediatric thyroid nodules and to tailor FNAB recommendations for children., Methods: Consecutive surgically resected paediatric thyroid nodules from two tertiary care centres between 2003 and 2021 were reviewed. Ultrasounds were blindly scored by radiologists according to TI-RADS. Management recommendations based on TI-RADS were evaluated. Various modelling methodologies were used to determine the optimal cutoff for FNAB in children., Results: Of the 96 patients, 79 (82%) were female and the median age at surgery was 16.1 years. Fifty (52%) nodules were malignant on surgical pathology. The area under the receiver operating characteristic curve of TI-RADS for predicting malignancy was 0.78. Adult TI-RADS recommendations would have resulted in 4% of cancerous nodules being lost to follow-up. Modifications to TI-RADS (FNAB of all TR3 nodules ≥1.5 cm, FNAB of TR4 and TR5 nodules ≥0.5 cm, surveillance of nodules ≥1 cm, consider surgery for nodules >4 cm) reduced this missed malignancy rate to 0%., Conclusions: TI-RADS can risk-stratify paediatric thyroid nodules. However, the system requires modifications to reduce the missed malignancy rate in paediatric thyroid nodules. Our data suggest that lower size thresholds for FNAB are warranted in children., (© 2024 The Author(s). Cytopathology published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
6. American Society of Cytopathology Telecytology validation recommendations for rapid on-site evaluation (ROSE).
- Author
-
Lin O, Alperstein S, Barkan GA, Cuda JM, Kezlarian B, Jhala D, Jin X, Mehrotra S, Monaco SE, Rao J, Saieg M, Thrall M, and Pantanowitz L
- Subjects
- Humans, Retrospective Studies, Biopsy, Fine-Needle, Software, Cytology, Rapid On-site Evaluation
- Abstract
Telecytology has multiple applications, including rapid onsite evaluation (ROSE) of fine-needle aspiration (FNA) specimens. It can enhance cytopathology practice by increasing productivity, reducing costs, and providing subspecialty expertise in areas with limited access to a cytopathologist. However, there are currently no specific validation guidelines to ensure safe practice and compliance with regulations. This initiative, promoted by the American Society of Cytopathology (ASC), intends to propose recommendations for telecytology implementation. These recommendations propose that the validation process should include testing of all hardware and software, both separately and as a whole; training of all individuals who will participate in telecytology with regular competency evaluations; a structured approach using retrospective slides with defined diagnoses for validation and prospective cases for verification and quality assurance. Telecytology processes must be integrated into the laboratory's quality management system and benchmarks for discrepancy rates between preliminary and final diagnoses should be established and monitored. Special attention should be paid to minimize discrepancies that downgrade malignant cases to benign (false positive on telecytology). Currently, billing and reimbursement codes for telecytology are not yet available. Once, they are, recommendation of the appropriate usage of these codes would be a part of the recommendations. These proposed guidelines are intended to be a resource for laboratories that are considering implementing telecytology. These recommendations can help to ensure the safe and effective use of telecytology and maximize its benefits for patients., (Copyright © 2024. Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF
7. An Atypical Presentation of Hepatocellular Carcinoma with Multisite Metastasis following a Curative Liver Transplant.
- Author
-
Gidley P, Patel A, Barkan GA, and Jawahar A
- Abstract
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy, and liver transplantation is usually curative. HCC recurrences are rare after curative treatment options, although they are prevalent depending on various risk factors. We present a 71-year-old female patient with an unusual pattern of disease progression following a curative liver transplant with a metastatic presentation in the absence of alpha-fetoprotein elevation after 3 years of disease-free clinical presentation. We present this case to emphasize the importance of intermittent cross-sectional imaging in addition to ultrasound screening in HCC surveillance., Competing Interests: Conflict of Interest None declared., (Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).)
- Published
- 2023
- Full Text
- View/download PDF
8. Current State of Cytologic-Histologic Correlation Implementation for North American and International Laboratories: Results of the College of American Pathologists Cytopathology Committee Laboratory Practices in Gynecologic Cytology Survey.
- Author
-
Nguyen LN, Crothers BA, Davey DD, Natale KE, Nunez AL, Harkcom T, Mody DR, Barkan GA, Souers RJ, Tabatabai ZL, and Booth CN
- Subjects
- Female, Humans, Cytodiagnosis, Quality Assurance, Health Care, United States, Laboratories, Pathologists, Societies, Medical
- Abstract
Context.—: The College of American Pathologists (CAP) updated the Laboratory Accreditation Program Cytopathology Checklist to assist laboratories in meeting and exceeding the Clinical Laboratory Improvement Amendments standards for gynecologic cytologic-histologic correlation (CHC)., Objective.—: To survey the current CHC practices., Design.—: Data were analyzed from a survey developed by the committee and distributed to participants in the CAP Gynecologic Cytopathology PAP Education Program mailing., Results.—: Worldwide, CHC practice is nearly universally adopted, with an overall rate of 87.0% (568 of 653). CHC material was highly accessible. CHC was commonly performed real time/concurrently at the time the corresponding surgical pathology was reviewed. Investigation of CHC discordances varied with North American laboratories usually having a single pathologist review all discrepant histology and cytology slides to determine the reason for discordance, while international laboratories have a second pathologist review histology slides to determine the reason for discordance. The cause of CHC discordance was primarily sampling issues. The more common statistical metrics for CHC monitoring were the total percentage of cases that correlated with subsequent biopsies, screening error rate by cytotechnologist, and interpretative error rate by cytotechnologist., Conclusions.—: Many laboratories have adopted and implemented the CHC guidelines with identifiable differences in practices between North American and international laboratories. We identify the commonalities and differences between North American and international institutional practices including where CHC is performed, how CHC cases are identified and their accessibility, when CHC is performed, who investigates discordances, what discordances are identified, and how the findings affect quality improvement., (© 2023 College of American Pathologists.)
- Published
- 2023
- Full Text
- View/download PDF
9. Telecytology validation: is there a recipe for everybody?
- Author
-
Trabzonlu L, Chatt G, McIntire PJ, Eshraghi R, Lapadat R, Atieh M, Pambuccian SE, Wojcik EM, Mehrotra S, and Barkan GA
- Subjects
- Humans, Biopsy, Fine-Needle methods
- Abstract
Introduction: Telecytology offers a suitable solution to the cost and time efficiency questions on rapid onsite evaluation (ROSE). An increasing number of institutions are adopting new telecytology systems to meet the increasing ROSE requests, although there is no agreement on the details of how a telecytology validation study needs to be conducted. We propose a standardized approach for telecytology validation studies that could be done in a variety of practices., Materials and Methods: Consecutive cases from 6 months prior were chosen to reflect a case mix comparable to real life. A fellow assessed the slides at the ROSE site while 6 cytopathology faculty convened in a conference room with a television screen, and noted the adequacy, diagnostic category, and specific diagnoses. All participants were blinded to the original adequacy assessment and final diagnoses. For each case, evaluation time and the slides counts were noted., Results: Fine-needle aspiration specimens from 52 patients were included in the study. Of these, 13 cases were used in the first "test" session. The adequacy concordance rates ranged between 92.3% and 100%, with an overall concordance rate of 94.8%. The diagnostic category concordance rates ranged between 90.3% and 95.5%, with an overall concordance rate of 91.9%. The specific diagnosis concordance rates ranged between 84.6% and 92.9%, with an overall concordance rate of 88.1%., Conclusions: Validation of telecytology requires a standardized approach just like any other new technology. In this study, we propose an efficient and accurate method for cytopathology departments of various case volumes to conduct telecytology validation studies., (Copyright © 2022 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
10. Adrenal gland cytology reporting: a multi-institutional proposal for a standardized reporting system.
- Author
-
Trabzonlu L, Jager L, Tabibi S, Compton ML, Weiss VL, Kanber Y, Robila V, Antic T, Maleki Z, Morency E, and Barkan GA
- Subjects
- Adrenal Glands pathology, Biopsy, Fine-Needle methods, Humans, Retrospective Studies, Salivary Glands pathology, Salivary Gland Neoplasms pathology
- Abstract
Background: With the development of new technologies and the changing patient profiles, cytopathology departments receive increasing numbers of adrenal gland cytology specimens. In this study, the authors analyzed archival adrenal gland cytology cases and attempted to implement a diagnostic reporting system., Design: Retrospective electronic medical record search was performed for adrenal gland cytology specimens in seven tertiary care centers. The cytology diagnoses were grouped in 7 categories: nondiagnostic, nonneoplastic, benign adrenal cortical elements (BACE), primary neoplasm of noncortical origin (NONC), atypia of undetermined significance (AUS), suspicious for malignancy (SM), and malignant (MAL). If available, histopathology results of concurrent and/or follow-up biopsies and/or resections were documented., Results: A total of 473 adrenal gland cytology cases were included. BACE cases comprised 21.8%, whereas MAL cases were 57.5% of all cases. For BACE and MAL categories, there were 100% and 98.9% correlation, respectively, in the cases with histopathology follow-up. Six of 10 NONC cases had histopathology diagnoses and there were 3 pheochromocytomas and 3 schwannomas. Twenty-one AUS cases had histology follow-up and 10 (47.6%) of them were malignant. Six cases of SM had histopathology follow-up, and all of them were malignant on the follow-up., Conclusions: The authors propose a 7-tier diagnostic scheme for adrenal gland cytology. The risk of malignancy was 98.9% in MAL cases (87/88) in the cohort. The only case with discordance was reported as "adrenal cortical adenoma with marked atypia"' on resection. There was no difference between endoscopic ultrasound-guided and percutaneous methods. Further studies are needed to validate and make this approach universal., (© 2022 American Cancer Society.)
- Published
- 2022
- Full Text
- View/download PDF
11. Digital image analysis of high-grade urothelial carcinoma in urine cytology confirms chromasia heterogeneity and reveals a subset with hypochromatic nuclei and another with extremely dark or "India ink" nuclei.
- Author
-
McIntire PJ, Aragao A, Burns BL, Pambuccian SE, Wojcik EM, and Barkan GA
- Subjects
- Cytodiagnosis methods, Female, Humans, Male, Urine, Urothelium pathology, Carcinoma, Transitional Cell diagnosis, Carcinoma, Transitional Cell pathology, Urinary Bladder Neoplasms pathology, Urologic Neoplasms urine
- Abstract
Background: The Paris System for Reporting Urinary Cytology (TPS) uses hyperchromasia as major diagnostic criterion for high-grade urothelial carcinoma (HGUC). The purpose of the study was to evaluate cases that were diagnosed as HGUC by TPS and determine whether there are different chromatin distribution patterns (ie, subsets)., Methods: Digital image annotations were performed on microscopic images of HGUC urine specimens with surgical biopsy/resection follow-up. Median gray values were generated for each cell. Neutrophils (polymorphonuclear leukocyte [PMN]) were also enumerated in each case to serve as an internal control. A HGUC/PMN ratio was generated for each case, and the cases were distributed., Results: Sixty-nine HGUC cases yielded 2660 cells, including 2078 HGUC (30.1 cells/case) and 582 PMNs (8.4 cells/case). The average median gray value of an HGUC was 50.6 and of a PMN was 36.8 (P < .0001). Eight of 69 cases (11.6%) contained nuclei that, on average, were darker than or as dark as a PMN (extremely dark, ie, "India ink"). Fifty-one of 69 cases (74.0%) contained nuclei that, on average, were slightly brighter than a PMN (hyperchromatic). Ten of 69 cases (14.5%) contained nuclei that, on average, were much brighter than a PMN (hypochromatic). Within a single case, all cases showed heterogeneity with the hypochromatic cases showing the most dramatic effect., Conclusions: Digital image analysis reveals that there are large variations in chromasia between cases including a subset of cases with hypochromasia and another with extremely dark or "India ink" nuclei. There was much heterogeneity of chromasia seen within a single sample., (© 2022 American Cancer Society.)
- Published
- 2022
- Full Text
- View/download PDF
12. Application of the Milan System for Reporting Salivary Gland Cytopathology in pediatric patients: An international, multi-institutional study.
- Author
-
Maleki Z, Saoud C, Viswanathan K, Kilic I, Tommola E, Griffin DT, Heider A, Petrone G, Jo VY, Centeno BA, Saieg M, Mikou P, Fadda G, Ali SZ, Kholová I, Wojcik EM, Barkan GA, Eisele DW, Bellevicine C, Vigliar E, Wiles AB, Al-Ibraheemi A, Allison DB, Dixon GR, Chandra A, Walsh JM, Baloch ZW, Faquin WC, Krane JF, Rossi ED, Pantanowitz L, Troncone G, Callegari FM, and Klijanienko J
- Subjects
- Adolescent, Adult, Biopsy, Fine-Needle, Child, Child, Preschool, Humans, Infant, Infant, Newborn, Retrospective Studies, Salivary Glands pathology, Young Adult, Precancerous Conditions diagnosis, Salivary Gland Neoplasms diagnosis, Salivary Gland Neoplasms pathology
- Abstract
Background: Pediatric salivary gland fine-needle aspiration (FNA) is uncommon with a higher frequency of inflammatory lesions and a small proportion of malignancies. This international, multi-institutional cohort evaluated the application of the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) and the risk of malignancy (ROM) for each diagnostic category., Methods: Pediatric (0- to 21-year-old) salivary gland FNA specimens from 22 international institutions of 7 countries, including the United States, England, Italy, Greece, Finland, Brazil, and France, were retrospectively assigned to an MSRSGC diagnostic category as follows: nondiagnostic, nonneoplastic, atypia of undetermined significance (AUS), benign neoplasm, salivary gland neoplasm of uncertain malignant potential (SUMP), suspicious for malignancy (SM), or malignant. Cytology-histology correlation was performed where available, and the ROM was calculated for each MSRSGC diagnostic category., Results: The cohort of 477 aspirates was reclassified according to the MSRSGC as follows: nondiagnostic, 10.3%; nonneoplastic, 34.6%; AUS, 5.2%; benign neoplasm, 27.5%; SUMP, 7.5%; SM, 2.5%; and malignant, 12.4%. Histopathologic follow-up was available for 237 cases (49.7%). The ROMs were as follows: nondiagnostic, 5.9%; nonneoplastic, 9.1%; AUS, 35.7%; benign neoplasm, 3.3%; SUMP, 31.8%; SM, 100%; and malignant, 100%. Mucoepidermoid carcinoma was the most common malignancy (18 of 237; 7.6%), and it was followed by acinic cell carcinoma (16 of 237; 6.8%). Pleomorphic adenoma was the most common benign neoplasm (95 of 237; 40.1%)., Conclusions: The MSRSGC can be reliably applied to pediatric salivary gland FNA. The ROM of each MSRSGC category in pediatric salivary gland FNA is relatively similar to the ROM of each category in adult salivary gland FNA, although the reported rates for the different MSRSGC categories are variable across institutions., (© 2022 American Cancer Society.)
- Published
- 2022
- Full Text
- View/download PDF
13. Splenogonadal Fusion: A Rare Mimicker of Malignancy.
- Author
-
Hartman NC, Trabzonlu L, Barkan GA, and Quek ML
- Abstract
Splenogonadal fusion is a rare congenital anomaly in which ectopic splenic tissue is found in the testis and can present as a testicular mass mimicking a testicular malignancy. We present a 27-year-old male who presented with a palpable left testis mass suspicious for malignancy and ultimately found to have discontinuous splenogonadal fusion after radical orchiectomy., Competing Interests: The authors have no relevant conflicts of interest to disclose., (Copyright © 2022 Natalie C. Hartman et al.)
- Published
- 2022
- Full Text
- View/download PDF
14. Unusual presentation of adrenal hemangioma as an incidental large adrenal hematoma - A case report.
- Author
-
Ploussard B, Kieffer A, Ramasamy SK, Barkan GA, and Jawahar A
- Subjects
- Adrenal Glands diagnostic imaging, Adrenal Glands pathology, Aged, Diagnostic Imaging, Female, Hematoma diagnostic imaging, Humans, Adrenal Gland Neoplasms complications, Adrenal Gland Neoplasms diagnostic imaging, Adrenal Gland Neoplasms surgery, Hemangioma complications, Hemangioma diagnostic imaging, Hemangioma pathology
- Abstract
Adrenal hemangiomas are exceedingly rare benign tumors. Hemangiomas are commonly found in the skin and liver. When they arise in the adrenal gland, they are typically found incidentally on imaging, large size at presentation and are usually surgically resected in view of their large size and heterogeneous imaging appearance. We present a 66-year-old female who presented with right abdominal pain and weight loss and was found to have a large adrenal hematoma arising from a hemangioma., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
15. Cytopathology fellowship recruitment: Has the time come to consider a unified approach?
- Author
-
Monaco SE, Nayar R, Wu RI, Staats PN, and Barkan GA
- Subjects
- Biopsy, Certification, Clinical Competence, Curriculum, Humans, Specialization, Time Factors, Cell Biology education, Cytological Techniques, Education, Medical, Graduate, Fellowships and Scholarships standards, Pathologists education, Pathology education, Personnel Selection standards
- Abstract
Introduction: Cytopathology (CYP) fellowship training is a critical component of maintaining a skilled group of cytopathologists. For years, the recruitment process for CYP fellowship programs has remained unchanged, with individual programs outlining their own requirements and timeline, and applicants bearing the cost of travel and dealing with the variable processes outlined by individual programs. However, there has been renewed interest in analyzing the recruitment process for CYP fellowships to look for areas of potential improvement and uniformity., Methods: With the goal of gauging the interest of CYP fellowship program directors (PDs) in a more unified approach to recruitment or a formal match process, the ASC Cytopathology Program Directors Committee (CPDC) surveyed PDs via SurveyMonkey and organized special webinars with polling over a 4-year time frame (2017-2021), and examined Qualtrics survey data collected by the American Board of Pathology (ABPath) in 2020., Results: The response rate for PDs was greatest in a formal survey by the ABPath (66 respondents; 71% of PDs) conducted in 2020, and lower for an ASC survey in 2021 (61 respondents, 66% of PDs) and 2017 (19 respondents; 21% of PDs) and two recent ASC webinars (10 and 26 respondents; 11% and 28% of PDs). Support for a fellowship match process varied from 29% to 77%, respondent uncertainty ranged from 13% to 50%, and a lack of support ranged from 10% to 60%. In aggregate, approximately 56% of respondents would be in favor of a more standardized process. Recently, after hearing about other fellowships experimenting with a standardized process, the interest in a unified approach doubled from approximately 29% to 60%, and the percentage of PDs with uncertainty decreased from 50% to 26%. In the most recent follow up survey, interest reached the highest level of 77% among PDs., Conclusions: Herein we present several years of feedback from the CYP fellowship PD community regarding a more standardized approach to CYP fellowship recruitment, culminating in the latest survey with 77% of CYP fellowship PDs expressing interest. Thus, details about what a unified timeframe may look like for CYP fellowships is presented to show how this may improve the recruitment process for the mutual benefit for programs and applicants., (Copyright © 2021. Published by Elsevier Inc.)
- Published
- 2021
- Full Text
- View/download PDF
16. "Bird's eye" cells in a pericardial effusion: Metastatic renal medullary carcinoma.
- Author
-
Mon KS, Kilic I, Barkan GA, and Pambuccian SE
- Subjects
- Adult, Humans, Male, Carcinoma, Medullary pathology, Carcinoma, Renal Cell pathology, Kidney Neoplasms pathology, Pericardial Effusion pathology
- Published
- 2021
- Full Text
- View/download PDF
17. Five-year retrospective review in gynecologic cytopathology: is it time to amend?
- Author
-
Nomani L, Abro S, Chatt G, Abdulameer S, Pambuccian SE, Mehrotra S, and Barkan GA
- Subjects
- Female, Humans, Mandatory Reporting, Papillomavirus Infections diagnosis, Papillomavirus Infections pathology, Quality Indicators, Health Care, Retrospective Studies, Squamous Intraepithelial Lesions pathology, Cytological Techniques methods, Cytological Techniques standards, Papanicolaou Test methods, Papanicolaou Test standards, Squamous Intraepithelial Lesions diagnosis
- Abstract
Introduction: According to the Clinical Laboratory Improvement Amendments 1988 regulations, 5-year retrospective review (5YRR) of normal Papanicolaou tests in patients with a newly diagnosed high grade squamous intraepithelial lesion or above (HSIL+) is mandatory. Since this mandate has been in place, a multitude of changes have taken place in the screening and management guidelines of cervical cancer. The aim of this study is to assess the role of this mandate in our laboratory and to investigate the lessons learned., Material and Methods: The cytopathology electronic database and institutional quality assurance records at Loyola University Medical Center were searched from January 2009 to December 2019 to identify all Papanicolaou tests diagnosed as new "HSIL and above" (HSIL+). Major discrepancy (2+) was defined as initial negative diagnosis changed to HSIL+., Results: A total of 153,083 Papanicolaou tests were performed during this period; out of these, 1452 (0.94%) were diagnosed as HSIL+. A total of 695 HSIL+ Papanicolaou tests had a negative prior Papanicolaou and in 615 of 695 there was agreement with the initial negative diagnosis. In 61 Papanicolaou tests, the initial diagnosis was changed from negative and they were reclassified on review as 3 HSIL, 9 ASC-H, 7 AGC, and 42 ASCUS or LSIL. Major discrepancy rate was calculated as 3 of 695 (0.43%). None required an amended report., Conclusions: It is important to revisit the 5YRR as a method of implementing the quality indicators in gynecologic cytology so that the process retains its value without overburdening cytology laboratories and personnel., (Copyright © 2021 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
18. Outcome analysis and negative predictive value of the "unsatisfactory/nondiagnostic" category of The Paris System for Reporting Urinary Cytology.
- Author
-
Abro S, Nomani L, Wojcik EM, Pambuccian SE, Chatt G, and Barkan GA
- Subjects
- Adult, Aged, Aged, 80 and over, Biopsy, Carcinoma surgery, Carcinoma urine, Databases, Factual, False Negative Reactions, Female, Humans, Male, Microscopy, Middle Aged, Neoplasm Grading, Predictive Value of Tests, Reproducibility of Results, Retrospective Studies, Urinalysis, Urologic Neoplasms surgery, Urologic Neoplasms urine, Young Adult, Carcinoma pathology, Early Detection of Cancer, Urine cytology, Urologic Neoplasms pathology, Urothelium pathology
- Abstract
Introduction: The Paris System (TPS) for Reporting Urinary Cytology (UCyto) was published in 2016, but to date, no study addressing the unsatisfactory (UNSAT) category has been published. We aimed to identify the negative predictive value (NPV) for UNSAT UCyto after the implementation of TPS at our institution., Method: For the period from January 1, 2017, to December 31, 2019, we identified all cases with UNSAT diagnosis on UCyto specimens and available cytologic and/or surgical pathology follow-up within 6 months from the UNSAT diagnosis. Cases were deemed true negative (TN) if the follow-up was "negative for high-grade urothelial carcinoma" (NHGUC). Information regarding previous medical history, clinical indications, and specimen type were tabulated and analyzed., Results: From 6348 UCyto specimens, there were 230 (3.6%) UNSAT diagnoses made on 209 patients (112 [53.6%] men and 97 [46.4%] women) with a median age of 64 years. Of these, 116 UCyto specimens from 106 patients, which had cytologic and/or surgical pathology follow-up within 6 months, were further studied. Most UNSAT UCyto specimens were bladder washing/barbotage (BW/BB), and the most common indication for UCyto was cancer surveillance. The main cause of UNSAT UCyto was low cellularity. There were 5 false-negative (FN) results for high-grade urothelial carcinoma (HGUC), which corresponds to an overall NPV of 84.4%. NPV was highest for patients with UCyto for hematuria, and for patients with BW/BB as UCyto specimen type., Conclusions: Our results show that UNSAT diagnoses have a lower NPV than that typical of NHGUC diagnoses, and should be managed accordingly., (Published by Elsevier Inc.)
- Published
- 2021
- Full Text
- View/download PDF
19. Assessing the diagnostic accuracy for pleomorphic adenoma and Warthin tumor by employing the Milan System for Reporting Salivary Gland Cytopathology: An international, multi-institutional study.
- Author
-
Allison DB, Smith AP, An D, Miller JA, Shafique K, Song S, Viswanathan K, Eykman E, Rao RA, Wiles A, Barkan GA, Nayar R, Fadda G, Powers CN, Rossi ED, Siddiqui MT, Ali SZ, Kholová I, Layfield LJ, Field A, Baloch Z, and Maleki Z
- Subjects
- Adenolymphoma pathology, Adenoma, Pleomorphic pathology, Adolescent, Adult, Aged, Aged, 80 and over, Biopsy, Fine-Needle, Child, Diagnosis, Differential, Female, Humans, Male, Middle Aged, Retrospective Studies, Salivary Gland Neoplasms pathology, Young Adult, Adenolymphoma diagnosis, Adenoma, Pleomorphic diagnosis, Salivary Gland Neoplasms diagnosis, Salivary Glands pathology
- Abstract
Background: The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) has established distinct diagnostic categories for reporting cytopathological findings, and each is associated with a defined risk of malignancy (ROM). However, the ROM is applied at the overall category level and is not specific for particular morphological entities within a category. Here, the diagnostic performance of the MSRSGC for pleomorphic adenoma (PA) and Warthin tumor (WT) is reported., Methods: The pathology archives of 11 institutions from 4 countries were retrospectively searched to identify all salivary gland fine-needle aspiration (FNA) biopsies with a differential or definitive diagnosis of PA or WT and all resection specimens with a diagnosis of PA or WT; only paired cases were included. All FNA diagnoses were retrospectively classified according to the MSRSGC., Results: A total of 1250 cases met the inclusion criteria, and they included 898 PA cases and 352 WT cases. The ROM in the benign neoplasm category was 3.0% and 1.3% for cases with a differential or definitive diagnosis of PA and WT, respectively. The ROM in the salivary gland neoplasm with uncertain malignant potential (SUMP) category was 2.7% and 18.8% for PA and WT, respectively (P = .0277). The diagnostic accuracy for PA and WT was 95.1% and 96.1%, respectively., Conclusions: The diagnostic accuracy for PA and WT on FNA is high. Furthermore, these findings highlight the difference in the ROMs associated with 2 specific differential diagnoses in the SUMP category: basaloid neoplasms and oncocytoid neoplasms., (© 2020 American Cancer Society.)
- Published
- 2021
- Full Text
- View/download PDF
20. The Paris System for Reporting Urinary Cytology reduces atypia rates and does not alter the negative predictive value of urine cytology.
- Author
-
McIntire PJ, Kilic I, Pambuccian SE, Wojcik EM, and Barkan GA
- Subjects
- Adult, Aged, Aged, 80 and over, Carcinoma urine, Databases, Factual, False Negative Reactions, Female, Humans, Male, Microscopy, Middle Aged, Neoplasm Grading, Predictive Value of Tests, Reproducibility of Results, Retrospective Studies, Urinalysis, Urologic Neoplasms urine, Young Adult, Carcinoma pathology, Early Detection of Cancer, Urine cytology, Urologic Neoplasms pathology, Urothelium pathology
- Abstract
Introduction: The Paris System for Reporting Urinary Cytology (TPS) was developed for standardization purposes and it placed an emphasis on screening for high-grade urothelial carcinoma (HGUC). Since then, it has shown to reduce atypia rates and better correlate with surgical specimens. The aim of this study was to calculate the negative predictive value (NPV) of urinary cytology for detecting HGUC using TPS and compare these data to our recently published pre-TPS cohort. As a screening test, it is imperative that TPS has a high NPV., Material and Methods: A search of our institution's pathology database for the term "negative for HGUC" from January 1, 2016, to December 31, 2017, was conducted. A true negative was defined as a patient with at least 1 subsequent negative urine cytology/surgical biopsy specimen or the patient being clinically negative for 6 months. NPV rates were calculated based on the data obtained., Results: The cohort consisted of 2960 urine cytology specimens from 1894 patients. A total of 99 false negatives were identified, generating a NPV of 96.7% (2861/2960). This NPV is identical to our previously published pre-TPS cohort (years 2012-2013; NPV: 96.7%). The clinical indication most effected NPV, with a history of urothelial carcinoma with a NPV of 93.9% followed by hematuria at 98.9%. The atypia rate in years 2012-2013 was 8.2% and in 2016-2017 it was 5.7% (P < 0.001)., Conclusions: We demonstrate that TPS did not alter the NPV for detecting HGUC compared to our pre-TPS cohort. We believe that TPS is an effective reporting system for screening HGUC in urinary cytology., (Copyright © 2020. Published by Elsevier Inc.)
- Published
- 2021
- Full Text
- View/download PDF
21. Accuracy of Subclassification and Grading of Renal Tumors on Fine Needle Aspiration Cytology Alone.
- Author
-
Chen HI, Lapadat R, Lastra RR, Biernacka A, Reeves W, Mueller J, Pambuccian SE, Barkan GA, Wojcik EM, and Antic T
- Subjects
- Azure Stains, Biopsy, Fine-Needle, Carcinoma, Renal Cell classification, Carcinoma, Renal Cell surgery, Humans, Kidney Neoplasms classification, Kidney Neoplasms surgery, Methylene Blue, Neoplasm Grading, Observer Variation, Papanicolaou Test, Predictive Value of Tests, Reproducibility of Results, Xanthenes, Carcinoma, Renal Cell pathology, Kidney Neoplasms pathology
- Abstract
Background: Fine needle aspiration (FNA) of renal masses can distinguish between benign and malignant neoplasms in 73-94% of cases. Previous studies suggested the correct subclassification of renal cell carcinomas (RCCs) by cytomorphology can be achieved in up to 80% of cases. However, as RCCs become increasingly subclassified by molecular signatures, correct subclassification based on cytology alone is increasingly difficult., Design: Two FNA passes (2 stained with Diff-Quik® and 2 with the Papanicolaou method) were performed on all fresh nephrectomy specimens for a 1-year period. There were 30 cases in this study, with 29 primary renal tumors and 1 case of metastatic lung adenocarcinoma. Each case was assigned a random number and came with 2 slides (1 from each staining method). Eight cytopathologists were asked to provide a diagnosis and the World Health Organization/International Society of Urological Pathology (WHO/ISUP) grading if applicable. Fleiss' Kappa and Cohen's Kappa equations were used to look at inter-rater variability., Results: When compared to the surgical pathology diagnosis, the average percent correct diagnosis for all cytopathologist was 35%. Chromophobe RCCs had the best average percent accuracy at 72% followed by clearcell RCC at 48%. Average accuracy for grading RCCs was 40%. Inter-rater variability among the cytopathologists for all RCC diagnoses was fair with a Fleiss' Kappa coefficient of 0.28. For the WHO/ISUP grade, the weighted coefficient for each pathologist ranged from 0.11 to 0.45, ranging from fair to moderate, respectively., Conclusions: Renal tumors are difficult to classify on cytopathology alone. Core needle biopsy and ancillary studies are necessary if diagnosis will change management., (© 2021 S. Karger AG, Basel.)
- Published
- 2021
- Full Text
- View/download PDF
22. Guar bean in urinary cytology: a morphologic pitfall.
- Author
-
Nomani L, Abro S, Quek ML, and Barkan GA
- Subjects
- Aged, Aged, 80 and over, Databases, Factual, Female, Galactans, Humans, Male, Mannans, Microscopy, Plant Gums, Predictive Value of Tests, Reproducibility of Results, Treatment Outcome, Urinalysis, Urinary Bladder Neoplasms pathology, Urinary Bladder Neoplasms urine, Cyamopsis, Cystectomy, Early Detection of Cancer, Seeds, Urinary Bladder Neoplasms surgery, Urinary Diversion instrumentation, Urine cytology
- Abstract
Introduction: Various types of contaminants can be encountered in cytologic specimens. This study describes a vegetable material that we encountered in ileal conduit urine specimens. We aim to describe the cytomorphology and the source of origin of this vegetable material., Material and Methods: The cytology database for the past 5 years (January 2015-April 2020) was searched for ileal conduit urine cytology specimens with a reported vegetable contaminant. The details of the ostomy procedure and device used were recorded. Histologic sections were prepared from the ostomy devices as well as from guar beans and seeds., Results: A total of 17 urinary specimens from 8 patients were identified that showed the presence of a vegetable contaminant. All the patients were using Coloplast (Minneapolis, MN) SenSura Mio ostomy device. The urine cytology showed presence of polygonal thick-walled cells with a dark brown/orange core with irregular outlines. Similar cells were also seen in the histologic sections prepared from the ostomy adhesive and the guar seed and bean., Conclusions: Guar gum is a naturally occurring hydrocolloid that is used in ostomy wafer adhesives. Correct identification and familiarity with the cytomorphology of the guar cells in samples of ileal conduit urine is essential to avoid a potential diagnostic pitfall when evaluating urine cytology specimens from these diversion specimens., (Copyright © 2020 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
23. Targeted education as a method for reinforcing Paris System criteria and reducing urine cytology atypia rates.
- Author
-
Compton ML, Weiss VL, Barkan GA, and Ely KA
- Subjects
- Carcinoma urine, Clinical Competence, Humans, Microscopy, Neoplasm Grading, Predictive Value of Tests, Reproducibility of Results, Urinalysis, Urologic Neoplasms urine, Carcinoma pathology, Early Detection of Cancer, Education, Medical, Continuing, Inservice Training, Laboratory Personnel education, Pathologists education, Urine cytology, Urologic Neoplasms pathology, Urothelium pathology
- Abstract
Introduction: The Paris System for Urine Cytology (TPS) provides well-defined diagnostic criteria for the category of atypical urothelial cells (AUC). The current study compares the rate of AUC diagnoses at a large academic medical center before and after an educational intervention (EI) by a urine cytology expert., Materials and Methods: An expert in TPS delivered an educational intervention consisting of an interactive microscope session and a didactic session that focused on the AUC diagnostic category. The number of urine cytology cases, the AUC rate, and the false-negative percentage were calculated before and after the EI, using the electronic medical records and cytologic-histologic correlation records., Results: A total of 4026 urine cytology cases were signed out in the 25 months prior to the educational intervention and 1585 cases were signed out in the 10 months after the intervention. EI had a significant impact on diagnostic categorization, including a reduction in AUC (19.6% versus 12.5%) and suspicious for high-grade urothelial carcinoma (3.9% versus 3.1%) diagnoses. The cytotechnologists also placed fewer cases into the AUC category during primary screening (27.6% versus 23.0%). Although a higher percentage of cases was reported as negative for high-grade urothelial carcinoma, the false-negative rate did not significantly change after the intervention (1.8% versus 2.0% of negative cases, P = 0.65)., Conclusions: Focused educational sessions for pathologists and cytotechnologists on the diagnostic criteria for AUC as defined by TPS can significantly reduce the rate of atypical diagnoses without a significant increase in the rate of false negatives., (Copyright © 2020 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
24. Experience on the use of The Paris System for Reporting Urinary Cytopathology: review of the published literature.
- Author
-
Pastorello RG, Barkan GA, and Saieg M
- Subjects
- Carcinoma urine, Humans, Microscopy, Neoplasm Grading, Predictive Value of Tests, Reproducibility of Results, Urinalysis, Urologic Neoplasms urine, Carcinoma pathology, Early Detection of Cancer, Urine cytology, Urologic Neoplasms pathology, Urothelium pathology
- Abstract
Introduction: The Paris System for Reporting Urinary Cytology (TPS) was first published in 2016 with clear objectives to standardize cytologic diagnostic criteria and provide uniform reporting, in order to improve patient stratification and associated clinical management. The aim of this paper is to evaluate the performance of TPS and review the literature published since TPS was introduced., Materials and Methods: Original articles focusing on the utilization and performance of TPS in urinary cytology specimens were identified using PubMed for publications from January 2016 to July 2020, using the keywords "Paris System", "urine cytology", and "urinary cytology"., Results: Twenty-three relevant articles in the literature regarding the use of TPS were included in the review from a total of 30,802 urine cytology specimens, of which 21,485 (69.8%) had available diagnoses. Distribution of cases among categories ranged from 50.5% to 95.3% for negative for high-grade urothelial carcinoma (NHGUC), 1.2% to 23% for atypical urothelial cells (AUC), 0.2% to 6.6% for suspicious for high-grade urothelial carcinomas (SHGUC), and 2.2% to 14.1% for high-grade urothelial carcinomas (HGUC). The calculated risk of high-grade malignancy (ROHM) ranged from 8.7% to 36.8% for NHGUC, 12.3% to 60.9%% for AUC, 33.3% to 100% for SHGUC, and 58.8% to 100% for HGUC. Mean ROHM weighted by sample size was calculated at 15.7% (±7.8%), 38.5% (±14.3%), 76.2% (±17.2%), and 88.8% (±12.7%) for NHGUC, AUC, SHGUC, and HGUC, respectively. Reported sensitivity of TPS ranged from 40% to 84.7%, specificity from 73% to 100%, PPV from 62.3% to 100%, and NPV from 46% to 90%., Conclusions: The application of TPS in the selected series has improved the screening and surveillance potential of urine cytology, while reducing high rates of indeterminate diagnoses, improving sensitivity and providing proper risk stratification for patients., (Copyright © 2020 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
25. The Paris system of Reporting Urinary Cytology: Strengths and opportunities.
- Author
-
Kurtycz DFI, Sundling KE, and Barkan GA
- Subjects
- Biopsy, Humans, Neoplasms diagnosis, Neoplasms pathology, Research Report standards, Urinary Bladder Neoplasms diagnosis, Urinary Bladder Neoplasms pathology, Cytodiagnosis, Urinary Tract cytology, Urinary Tract pathology, Urologic Neoplasms diagnosis, Urologic Neoplasms pathology, Urothelium cytology, Urothelium pathology
- Abstract
The Paris system for reporting urinary cytopathology (TPS) was created to address inherent weaknesses inherent in the practice of urinary cytopathology. While urothelial cytology has always performed well at finding high grade, genetically unstable urothelial carcinoma, it performs poorly when it comes to detecting low-grade urothelial neoplasia. TPS intends to improve the utility of urothelial cytology by focusing on what is important, high-grade urothelial carcinoma. This article is a snapshot of the current state of TPS as it heads into its second edition. Successes are described and further developments are considered., (© 2020 Wiley Periodicals LLC.)
- Published
- 2020
- Full Text
- View/download PDF
26. Small core needle biopsies in cytology practice: a survey of members of the American Society of Cytopathology.
- Author
-
Thrall MJ, Vrbin C, Barkan GA, Monaco SE, Pambuccian SE, Pantanowitz L, Pitman MB, and Kurtycz DFI
- Subjects
- Biopsy, Large-Core Needle methods, Canada, Humans, Laboratories, Hospital, Needles classification, Precision Medicine methods, United States, Endoscopic Ultrasound-Guided Fine Needle Aspiration methods, Health Knowledge, Attitudes, Practice, Pathologists psychology, Pathology, Surgical methods, Societies, Medical, Surgeons psychology, Surveys and Questionnaires
- Abstract
Introduction: The introduction of a new generation of core needle biopsies (CNBs) for endoscopic procedures has prompted reconsideration of the role of cytopathologists in the handling of small biopsies. The American Society of Cytopathology (ASC) has therefore conducted a survey with the intention of elucidating current practices regarding the handling of small CNBs., Materials and Methods: The membership of the ASC was invited by email to participate in an online survey over a 2-month period. The survey consisted of 20 multiple choice questions with 2-8 possible responses per question., Results: Of 2651 members contacted by e-mail, 282 (10.6%) responded to the survey questions, including 196 pathologists (69.5%) and 86 cytotechnologists (30.5%). Of these, 265 respondents were from the US/Canada (94.0%), with 156 from academic institutions (58.9%) and 109 from non-academic practices (41.1%); 17 were from other countries (6.0%). In 18.8% of all practices, cytopathologists sign out >90% of small CNBs from endoscopic and radiologically guided procedures; in 36.5% of practices >90% are signed out by surgical pathologists; the remainder have such cases divided more evenly between cytopathologists and surgical pathologists. Responses show that 78.0% of all respondents are interested in signing out more small biopsies in the future, and 80.5% desire increased small biopsy-related resources from the ASC., Conclusions: The survey responses indicate that practices currently vary widely across institutions. Most indicated an interest in greater incorporation of small biopsies into the practice of cytopathology., (Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
27. An international outreach from the American Society of Cytopathology: Worldvision Cytopathology Contest.
- Author
-
Barkan GA, Jenkins E, and Rossi ED
- Subjects
- Communication, Cytodiagnosis methods, Humans, Utah, International Cooperation, Medical Laboratory Personnel psychology, Pathologists psychology, Societies, Medical, Societies, Scientific, Students, Medical psychology
- Abstract
In an effort to be more inclusive and embrace the international cytology community, the American Society of Cytopathology formed the International Liaison and Membership (ILM). The Worldvision Cytopathology Contest was designed by the co-chairs of this committee (Drs. Güliz A. Barkan and Esther Diana Rossi) as an opportunity of scientific exchange in the international cytology community. The idea took its inspiration from the well-known song contest, the "Eurovision Song Contest" a competition among international singers, which started as a "light entertainment" in the 1950's to bring together a war-torn Europe. The goals of this session were to bring the worldwide cytology community together, to increase the international participation to the ASC, to attract a younger generation of pathology professionals to cytopathology, to provide education on interesting cases for the participants, and to provide training for international contestants on how to give good public presentations. The contest was successfully done at the 2019 annual meeting, and the winner was Dr. Elena Vigliar from Italy. The Worldvision Cytopathology Contest will be performed again in future meetings., (Copyright © 2020 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
28. Corrigendum to "Immunohistochemistry in the workup of bladder biopsies. Frequency, variation and utility of use at an academic center" [Ann. Diagn. Pathol. 41(2019) 124-128].
- Author
-
McIntire P, Khan R, Kilic I, Adams D, Karakaş C, Wojcik EM, Pambuccian SE, and Barkan GA
- Published
- 2020
- Full Text
- View/download PDF
29. Current state of Grand Rounds in U.S. pathology training programs.
- Author
-
Kilic I, Nigdelioglu R, Lapadat R, Ananthanarayanan V, Barkan GA, Wojcik EM, and Pambuccian SE
- Subjects
- Adult, Education, Medical, Graduate standards, Female, Gender Equity, Humans, Internship and Residency, Male, United States, Education, Medical, Graduate methods, Pathology education, Teaching Rounds
- Abstract
Grand Rounds are held with variable frequency in many academic pathology departments, but their exact goal is uncertain, and the type of subjects covered, and presenters have not been studied. We aimed to gather information about the current state of pathology grand rounds (PGR). We identified all US pathology residency programs accredited by the Accreditation Council for Graduate Medical Education (ACGME) and searched their websites for information regarding PGR, extracting data on their existence, frequency and timing. For a representative subgroup of institutions from all US regions and program sizes, we tabulated the 2017-2018 PGR titles and presenters (gender, degree(s), resident/fellow, faculty academic rank). We found that 71 of 142 (50%) ACGME-accredited programs had PGR, more often in programs with >12 residents (53/88, 60%). PGR were scheduled most commonly weekly, on Thursdays, and at noon. We analyzed 1019 PGR presentations from 41 institutions located in 26 US states. Among the 1105 presenters, 183 (16.56%) were trainees, 74 (6.7%) were non-academic, and 848 (76.7%) were faculty, 559 male and 289 female (M/F = 1.93). M/F ratio increased with academic rank, from 1.0 (117/115) for assistant, to 2.0 (135/68) for associate, and 2.9 (307/106) for full professors. Topics covered by PGR belonged to anatomic pathology (357), clinical pathology (209), research (184) or other medical or surgical specialties (149). Our study suggests that trainees are a major intended audience of pathology grand round. Unfortunately, there is a gender gap among pathology grand round presenters that widens with increasing academic rank of presenters., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
30. The utilization and utility of immunostains in body fluid cytology.
- Author
-
Alshaikh S, Lapadat R, Atieh MK, Mehrotra S, Barkan GA, Wojcik EM, and Pambuccian SE
- Subjects
- Body Fluids cytology, Diagnosis, Differential, Humans, Neoplasms metabolism, Pathologists standards, Pathologists statistics & numerical data, Pathology, Clinical methods, Pathology, Clinical standards, Pathology, Clinical statistics & numerical data, Practice Patterns, Physicians' standards, Practice Patterns, Physicians' statistics & numerical data, Reproducibility of Results, Retrospective Studies, Sensitivity and Specificity, Staining and Labeling methods, Biomarkers, Tumor metabolism, Body Fluids metabolism, Cytodiagnosis methods, Immunohistochemistry methods, Neoplasms diagnosis
- Abstract
Background: Body fluid cytology (BFC) is an important tool in the diagnosis and staging of malignancy and is aided by the judicious use of immunohistochemistry (IHC). The aim of this study was to determine the usage rates of IHC stains in BFC, their type and indications, and their diagnostic impact. We also attempted to estimate the optimal rate of IHC use in BFC by comparing the entire laboratory's and each individual cytopathologist's IHC use rates with their respective indeterminate and malignant diagnosis rates., Methods: We conducted a retrospective study of IHC stain use in BFC during a 5.5-year interval (2013-2018) and determined the laboratory's and each individual cytopathologist's IHC usage patterns according to the final diagnosis, site, and indications for their use., Results: A total of 477 out of 4144 (11.5%) BFC cases had 2128 individual immunostains performed, with an average of 4.5 immunostains per case. Individual cytopathologists used IHC stains on 6.7% to 22% of their BFC cases. Pathologists with higher rates of IHC stain use than the laboratory's mean were less experienced and had higher rates of indeterminate but not of malignant diagnoses. The most common indication for the use of IHC stains was differentiating mesothelial from malignant cells. MOC31, calretinin, Ber-EP4, CD68, and D2-40 were the most commonly used of the 67 different IHC stains used in BFC., Conclusions: The laboratory's mean may represent the optimal IHC use rate, as higher IHC use rates did not lead to more diagnostic certainty or higher pickup rates of malignant cells., (© 2020 American Cancer Society.)
- Published
- 2020
- Full Text
- View/download PDF
31. Practice Patterns in Urinary Cytopathology Prior to the Paris System for Reporting Urinary Cytology.
- Author
-
Barkan GA, Tabatabai ZL, Kurtycz DFI, Padmanabhan V, Souers RJ, Nayar R, and Sturgis CD
- Subjects
- Humans, Laboratories, Surveys and Questionnaires, Cytodiagnosis methods, Pathology, Clinical methods, Urinalysis methods
- Abstract
Context.—: The Paris System for Reporting Urinary Cytology has been disseminated since its inception in 2013; however, the daily practice patterns of urinary tract cytopathology are not well known., Objective.—: To assess urinary tract cytopathology practice patterns across a variety of pathology laboratories to aid in the implementation and future update of the Paris System for Reporting Urinary Cytology., Design.—: A questionnaire was designed to gather information about urinary tract cytopathology practices and mailed in July 2014 to 2116 laboratories participating in the College of American Pathologists interlaboratory comparison program. The participating laboratories' answers were summarized., Results.—: Of the 879 of 2116 laboratories (41%) that participated, 745 (84.8%) reported processing urinary tract specimens in house. The laboratories reported processing various specimen types: voided urine, 735 of 738 (99.6%); bladder washing/barbotage, 639 of 738 (86.6%); and catheterized urine specimens, 653 of 738 (88.5%). Some laboratories used multiple preparation methods, but the most commonly used preparation techniques for urinary tract specimens were ThinPrep (57.4%) and Cytospin (45.5%). Eighty-eight of 197 laboratories (44.7%) reported preparing a cell block, but with a low frequency. Adequacy criteria were used by 295 of 707 laboratories (41.7%) for voided urine, and 244 of 707 (34.5%) assessed adequacy for bladder washing/barbotage. More than 95% of the laboratories reported the use of general categories: negative, atypical, suspicious, and positive. Polyomavirus was classified as negative in 408 of 642 laboratories (63.6%) and atypical in 189 of 642 (29.4%). One hundred twenty-eight of 708 laboratories (18.1%) performed ancillary testing, and of these, 102 of 122 (83.6%) reported performing UroVysion., Conclusions.—: Most laboratories use the ThinPrep method followed by the Cytospin technique; therefore, the criteria published in The Paris System for Reporting Urinary Cytology , based mostly on ThinPrep and SurePath, should be validated for Cytospin, and relevant information should be included in the revised edition of The Paris System for Reporting Urinary Cytology .
- Published
- 2020
- Full Text
- View/download PDF
32. Split-sample comparison of urothelial cells in ThinPrep and cytospin preparations in urinary cytology: Do we need to adjust The Paris System for Reporting Urinary Cytology criteria?
- Author
-
Richardson CJ, Pambuccian SE, and Barkan GA
- Subjects
- Adult, Aged, Aged, 80 and over, Biopsy standards, Carcinoma, Transitional Cell pathology, Carcinoma, Transitional Cell urine, Cell Nucleus pathology, Cytoplasm pathology, Female, Humans, Male, Middle Aged, Neoplasm Grading standards, Practice Guidelines as Topic, Prospective Studies, Urologic Neoplasms pathology, Urologic Neoplasms urine, Urothelium cytology, Urothelium pathology, Carcinoma, Transitional Cell diagnosis, Histocytological Preparation Techniques methods, Urine cytology, Urologic Neoplasms diagnosis
- Abstract
Background: The Paris System for Reporting Urinary Cytology (TPS) defines clear morphologic criteria to classify urinary specimens into 7 diagnostic categories. According to TPS, a nuclear-to-cytoplasmic ratio (N:C ratio) >0.7 and hyperchromasia must be observed to render a diagnosis of high-grade urothelial carcinoma (HGUC). TPS was established using only liquid-based preparation techniques, and to the authors' knowledge it is unknown whether TPS can be applied using other preparation methods., Methods: In the current prospective study, voided urine samples from patients with HGUC and negative for HGUC (NHGUC) were prepared using both ThinPrep and cytospin methods. ImageJ image processing software was used to measure the N:C ratio and hyperchromasia. For each patient, the N:C ratio and degree of hyperchromasia of urothelial cells present in both cytopreparations were compared., Results: A total of 10 HGUC cases and 9 NHGUC cases, represented by a total of 688 cells (mean, 36.7 cells in HGUC cases; and mean, 35.8 cells in NHGUC cases), were evaluated in the current study. An overall comparison of HGUC cells with NHGUC cells demonstrated that HGUC cells had a higher average N:C ratio (0.5465 vs 0.2846) and greater hyperchromasia as measured by the average nuclear pixel gray value (100.8 vs 120.7). The N:C ratio was statistically different in 4 NHGUC cases, demonstrating higher N:C ratios in the ThinPrep preparations. Hyperchromasia was found to be statistically different in 6 cases, 5 of which demonstrated increased hyperchromasia in the ThinPrep specimens., Conclusions: The morphologic features of HGUC cells appear to be similar in samples prepared using the ThinPrep and cytospin methods, and therefore TPS criteria may be applied successfully in laboratories that use these methods., (© 2019 American Cancer Society.)
- Published
- 2020
- Full Text
- View/download PDF
33. Mutational Profile Using Next-Generation Sequencing May Aid in the Diagnosis and Treatment of Urachal Adenocarcinoma.
- Author
-
Cornejo KM, Cosar EF, Paner GP, Yang P, Tomaszewicz K, Meng X, Mehta V, Sirintrapun SJ, Barkan GA, and Hutchinson L
- Subjects
- Adenocarcinoma diagnosis, Adenocarcinoma pathology, Adenocarcinoma therapy, Clinical Decision-Making, Diagnosis, Differential, Humans, Molecular Targeted Therapy, Retrospective Studies, Urinary Bladder Neoplasms diagnosis, Urinary Bladder Neoplasms pathology, Urinary Bladder Neoplasms therapy, Adenocarcinoma genetics, Biomarkers, Tumor genetics, High-Throughput Nucleotide Sequencing, Mutation, Urinary Bladder Neoplasms genetics
- Abstract
Objectives . The rare urachal adenocarcinoma (UAC) of the bladder has striking morphologic and immunohistochemical overlap with colorectal adenocarcinoma (CAC) and bladder adenocarcinoma (BAC). To date, the mutational status in UAC and BAC has not been well investigated. Methods . We retrospectively evaluated 34 UACs (mucinous, n = 9; intestinal, n = 3; signet ring cell, n = 1; not otherwise specified, n = 21) and 4 BACs (n = 4). Next-generation sequencing analysis of 50 cancer "hotspot" gene mutations using the Ampliseq Cancer Hotspot Panel v2 was performed. Two UAC cases did not have adequate DNA quality with poor sequencing coverage and were excluded from the study. Results. RAS mutations were identified in 16 of 32 (50%) UACs (15 KRAS ; 1 NRAS ) and none of the BACs (0%). TP53 mutations were found in both UACs (18/32; 56%) and BACs (4/4; 100%). GNAS (n = 4), SMAD4 (n = 3), and BRAF (n = 1) mutations were only found in UACs. In contrast, APC (n = 2) mutations were only found in BACs. The mucinous subtype of UAC contained a SMAD4 mutation in 33% of cases (3/9), which was not identified in any other subtype (0/23; 0%) ( P = .0169). The only BRAF mutation was identified in the single signet ring cell subtype of UAC. There were no other differences in the mutation profile when comparing histologic subtypes of UAC. Conclusions . In summary, UAC and BAC have overlapping but distinct mutation profiles and these differences may aid in separating these 2 entities. Next-generation sequencing to identify therapeutic targets or resistance markers may aid treatment decisions.
- Published
- 2020
- Full Text
- View/download PDF
34. Penile Paget's Disease: A Case Report and Review of the Literature.
- Author
-
Flanigan RC, Dornbier R, Quek ML, Woods M, Gorbonos A, Gupta G, Harkenrider MM, Solanki A, Badami A, Henry E, Berg S, Bova D, Barkan GA, and Picken MM
- Abstract
Extramammary Paget's Disease (EMPD) is a rare cutaneous, slow growing, intraepithelial adenocarcinoma that can be either primary (intraepithelial arising within the epidermis) or secondary (intraepithelial spread of a visceral carcinoma). Here we present the case of a 63-year-old male with EMPD of the glans penis stemming from underlying urothelial carcinoma. Our treatment decision elected for management with chemotherapy and local treatment with radiation therapy. Subsequent, review of the literature demonstrated a rare disease with a variety of underlying malignancies causing this secondary pathology. Caregivers should be aware of the association of Paget's disease and urothelial cancer and should have a high index of suspicion that erythematous penile lesions may represent Paget's disease and that penile biopsies should be performed early in this setting.
- Published
- 2020
- Full Text
- View/download PDF
35. The color of urine: then and now-a comprehensive review of the literature with emphasis on intracytoplasmic pigments encountered in urinary cytology.
- Author
-
McIntire PJ, Kilic I, Wojcik EM, Barkan GA, and Pambuccian SE
- Subjects
- Adult, Aged, Aged, 80 and over, Color, Diagnosis, Differential, Female, Hemosiderin urine, Humans, Male, Melanins urine, Melanoma diagnosis, Melanoma urine, Melanosis diagnosis, Melanosis urine, Middle Aged, Pigmentation, Skin Neoplasms diagnosis, Skin Neoplasms urine, Cytodiagnosis methods, Cytoplasm chemistry, Lipofuscin urine, Pigments, Biological urine, Urine cytology
- Abstract
The color of urine, once considered by uroscopists to give the most important clues to the diagnosis, still can provide some diagnostic clues in modern medicine. Pigmented cells are an uncommon and surprising find in urine cytology and can at the same time provide important diagnostic clues or represent a dangerous pitfall. We present a review of the significance of pigmented cells in urine cytology. The presence of intracellular pigment granules; their color, size, shape, and variation in size and shape; as well as their staining reactions with special stains can provide useful diagnostic insight, especially when interpreted in the cytologic context (type of pigmented cell and its degree of atypicality) and patient's clinical context. The main differential diagnosis of cytoplasmic pigmented granules includes hemosiderin, lipofuscin, and melanin, each having a different pathogenesis and significance. The goal of this paper is to describe the morphological, histochemical, and ultrastructural characteristics of the pigments seen in urinary cytology, and to review the benign and malignant conditions associated with them., (Copyright © 2020 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
36. Rhabdoid cells in the fine needle aspirate of a neck mass in a patient with history of melanoma: Anaplastic thyroid carcinoma.
- Author
-
Eshraghi R, Barkan GA, and Pambuccian SE
- Subjects
- Aged, Biopsy, Fine-Needle, Cell Nucleus pathology, Humans, Male, Head and Neck Neoplasms pathology, Melanoma pathology, Neck pathology, Thyroid Carcinoma, Anaplastic pathology
- Published
- 2019
- Full Text
- View/download PDF
37. Lipofuscin pigmentation (so called "melanosis") of the bladder.
- Author
-
Atieh M, McIntire PJ, Kilic I, Picken MM, Flanigan RC, Barkan GA, and Pambuccian SE
- Subjects
- Aged, Female, Humans, Lipofuscin metabolism, Melanosis metabolism, Melanosis pathology, Pigmentation, Urinary Bladder metabolism, Urinary Bladder pathology, Urothelium metabolism, Urothelium pathology
- Published
- 2019
- Full Text
- View/download PDF
38. Mucoepidermoid carcinoma, acinic cell carcinoma, and adenoid cystic carcinoma on fine-needle aspiration biopsy and The Milan System: an international multi-institutional study.
- Author
-
Miller JA, An D, Shafique K, Song S, Rao RA, Viswanathan K, Eykman E, Wiles A, Ali SZ, Field A, Fadda G, Barkan GA, Layfield LJ, Rossi ED, Powers CN, Siddiqui MT, Kholova I, Baloch Z, and Maleki Z
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Biopsy, Fine-Needle, Female, Humans, Male, Middle Aged, Risk Factors, Young Adult, Carcinoma, Acinar Cell pathology, Carcinoma, Adenoid Cystic pathology, Carcinoma, Mucoepidermoid pathology, Internationality, Salivary Gland Neoplasms pathology, Salivary Glands pathology
- Abstract
Background: We evaluated the diagnostic accuracy (DA), risk of neoplasm (RON), and risk of malignancy (ROM) for the commonly encountered malignant salivary gland tumors mucoepidermoid carcinoma (MECa), acinic cell carcinoma (ACCa), and adenoid cystic carcinoma (ADCa) applying The Milan System for Reporting Salivary Gland Cytology (MSRSGC)., Materials and Methods: The cytology archives from 2007 to 2017 of 9 academic institutions were searched for salivary gland FNAs for the following key words mentioned either in the principal and/or differential diagnosis: MEC, ACCa, and ADCa. The original cytology diagnosis was retrospectively classified according to the MSRSGC. Patient demographics, biopsy site, and available surgical follow-up were recorded. The final analysis included only cases with surgical follow-up., Results: A total of 212 salivary gland FNAs were included. Based on retrospective reclassification according to MSRSGC, 97 of 212 (46%) FNA cases carried a diagnosis of malignancy specific for either MECa, ACCa, or ADCa. In the remaining 115 cases, 24 of 212 (11%) were reclassified as suspicious for malignancy (SM) and 91 of 212 (43%) as salivary gland neoplasm of uncertain malignant potential (SUMP). The DA for MECa, ACCa, and ADCa was 78.7%, 75% and 89%, respectively. The RON was 100% for all 3 tumors and the ROM was 93.6% for MECa, 96.8% for ACCa, and 94.4% for ADCa., Conclusions: The DA of 78.7% for MECa, 75% for ACCa, and 89% for ADCa is reasonable in FNA specimens. Although the management of definitive cases of malignancy remains unchanged, the MSRSGC provides a ROM for SM and SUMP categories, which can improve patient management., (Copyright © 2019 American Society of Cytopathology. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
39. "Teardrop," "comet," and "bowling-pin" cells in a hobnail variant of papillary thyroid carcinoma fine needle aspirate.
- Author
-
Mehrotra S, Lapadat R, Barkan GA, and Pambuccian SE
- Subjects
- Aged, Female, Humans, Thyroid Cancer, Papillary pathology, Thyroid Neoplasms pathology
- Published
- 2019
- Full Text
- View/download PDF
40. Immunohistochemistry in the workup of bladder biopsies: Frequency, variation and utility of use at an academic center.
- Author
-
McIntire P, Khan R, Kilic I, Wojcik EM, Pambuccian SE, and Barkan GA
- Subjects
- Adult, Aged, Aged, 80 and over, Biopsy, Female, Humans, Male, Middle Aged, Biomarkers, Tumor analysis, Carcinoma in Situ diagnosis, Carcinoma, Transitional Cell diagnosis, Immunohistochemistry statistics & numerical data, Urinary Bladder Neoplasms diagnosis
- Abstract
Introduction: Flat urothelial lesions fall into one of four diagnostic categories including urothelial carcinoma in-situ (CIS). There is morphologic overlap between the categories leading to immunohistochemistry (IHC) utilization in difficult cases. The purpose of this study was to examine the frequency, variation and utility of IHC use in bladder biopsy specimens over a 17 year period., Methods: A search of "CD44", "p53", and "CK20" keywords was conducted from the pathology files (1/1/2003 to 12/31/2017) on bladder biopsy specimens at our institution. Atypical (AUS), dysplastic (UD) and CIS rates were calculated., Results: A total of 4597 cases were identified. IHC was performed on 345 specimens (7.5%, 345/4597). For cases without IHC (H&E only), the AUS rate was 4.8% (206/4252), UD rate was 9.4% (399/4252), and the CIS rate was 8.4% (359/4252). For IHC cases, the AUS rate was 5.2% (18/345), the UD rate was 8.1% (28/345), and the CIS rate was 11.3% (39/345). There was no statistical difference between the H&E only or IHC rates (p > 0.05). The absolute number IHC orders per year increased until 2011 (60 cases) but drastically declined over the last five years (5 total cases in 2017). The CIS rates have remained relatively constant., Conclusion: We found the AUS, UD and CIS rates were similar regardless of IHC use. Our institution was an early adopter of IHC and it quickly fell out of favor. We agree with the ISUP in that IHC has limited clinical utility for flat urothelial lesions and morphology remains the gold standard., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
41. Fine needle aspiration diagnosis of metastatic Leydig cell tumor. Report of a case and review of the literature.
- Author
-
Biemer J, Pambuccian SE, and Barkan GA
- Subjects
- Adult, Aged, Biopsy, Fine-Needle, Fatal Outcome, Humans, Ilium, Immunohistochemistry, Liver pathology, Male, Middle Aged, Pelvic Neoplasms surgery, Leydig Cell Tumor diagnosis, Lymph Nodes pathology, Pelvic Neoplasms secondary, Rare Diseases diagnosis, Testicular Neoplasms diagnosis
- Abstract
Leydig cell tumors are rare sex cord-stromal tumors that account for less than 1% of all testicular tumors. Less than 10% of these tumors show metastatic malignant behavior. Herein we present a case of metastatic malignant Leydig cell tumor in an iliac lymph node diagnosed on fine-needle aspiration (FNA) in a 70-year-old man. The patient was referred from an outside institution with lymphadenopathy and had a past medical history of lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia and past surgical history of orchiectomy. An iliac lymph node FNA was performed demonstrating large discohesive plasmacytoid cells with indistinct cell borders; abundant and finely granular cytoplasm; round, eccentric nuclei with evenly distributed chromatin; and prominent nucleoli. The tumor cells were positive for inhibin and negative for calretinin and keratin leading to the diagnosis of metastatic malignant Leydig cell tumor. Review of the patient's history and of previous pathologic material, careful evaluation of cytomorphologic features, and the judicious use of immunohistochemistry can allow an accurate diagnosis of metastatic Leydig cell tumor., (Copyright © 2019 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
42. Application of the Milan System for Reporting Submandibular Gland Cytopathology: An international, multi-institutional study.
- Author
-
Maleki Z, Baloch Z, Lu R, Shafique K, Song SJ, Viswanathan K, Rao RA, Lefler H, Fatima A, Wiles A, Jo VY, Wang H, Fadda G, Powers CN, Ali SZ, Pantanowitz L, Siddiqui MT, Nayar R, Klijanienko J, Barkan GA, Krane JF, Rossi ED, Callegari F, Kholová I, Bongiovanni M, Faquin WC, and Pusztaszeri MP
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Algorithms, Biopsy, Fine-Needle, Child, Child, Preschool, Female, Follow-Up Studies, Health Facilities, Humans, Infant, International Agencies, Male, Medical Records statistics & numerical data, Middle Aged, Retrospective Studies, Young Adult, Cytodiagnosis methods, Cytodiagnosis standards, Precancerous Conditions diagnosis, Risk Assessment methods, Salivary Gland Neoplasms classification, Salivary Gland Neoplasms diagnosis, Submandibular Gland pathology
- Abstract
Background: The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) is a 6-tier diagnostic category system with associated risks of malignancy (ROMs) and management recommendations. Submandibular gland fine-needle aspiration (FNA) is uncommon with a higher frequency of inflammatory lesions and a higher relative proportion of malignancy, and this may affect the ROM and subsequent management. This study evaluated the application of the MSRSGC and the ROM for each diagnostic category for 734 submandibular gland FNAs., Methods: Submandibular gland FNA cytology specimens from 15 international institutions (2013-2017) were retrospectively assigned to an MSRSGC diagnostic category as follows: nondiagnostic, nonneoplastic, atypia of undetermined significance (AUS), benign neoplasm, salivary gland neoplasm of uncertain malignant potential (SUMP), suspicious for malignancy (SM), or malignant. A correlation with the available histopathologic follow-up was performed, and the ROM was calculated for each MSRSGC diagnostic category., Results: The case cohort of 734 aspirates was reclassified according to the MSRSGC as follows: nondiagnostic, 21.4% (0%-50%); nonneoplastic, 24.2% (9.1%-53.6%); AUS, 6.7% (0%-14.3%); benign neoplasm, 18.3% (0%-52.5%); SUMP, 12% (0%-37.7%); SM, 3.5% (0%-12.5%); and malignant, 13.9% (2%-31.3%). The histopathologic follow-up was available for 333 cases (45.4%). The ROMs were as follows: nondiagnostic, 10.6%; nonneoplastic, 7.5%; AUS, 27.6%; benign neoplasm, 3.2%; SUMP, 41.9%; SM, 82.3%; and malignant, 93.6%., Conclusions: This multi-institutional study shows that the ROM of each MSRSGC category for submandibular gland FNA is similar to that reported for parotid gland FNA, although the reported rates for the different MSRSGC categories were variable across institutions. Thus, the MSRSGC can be reliably applied to submandibular gland FNA., (© 2019 American Cancer Society.)
- Published
- 2019
- Full Text
- View/download PDF
43. Urothelial Carcinoma Recurrence in an Orthotopic Neobladder without Urethral or Upper Urinary Tract Involvement.
- Author
-
Doshi CP, Barkan GA, and Quek ML
- Abstract
We describe a case of a 71-year-old male with an isolated recurrence of urothelial carcinoma in an ileal neobladder without involvement of the upper urinary tract or urethra. He was diagnosed with high grade urothelial carcinoma involving a bladder diverticulum with associated carcinoma in situ. He underwent a radical cystectomy and orthotopic Studer ileal neobladder. On routine follow-up, 11 years following cystectomy, voided urine cytology was positive for high grade urothelial carcinoma. Further workup revealed normal upper urinary tracts, normal urethra, and a solitary lesion at the left anteroinferior wall of the neobladder. He subsequently underwent resection of the neobladder and conversion to an ileal conduit with pathology confirming the diagnosis of high grade urothelial carcinoma. Isolated recurrence of urothelial carcinoma within a neobladder without involvement of the upper urinary tract or urethra is rare. No guidelines exist regarding its management. Herein we present our management as well as the current literature published on this topic.
- Published
- 2019
- Full Text
- View/download PDF
44. Splendore-Hoeppli phenomenon in a fine needle aspirate of cervicofacial actinomycosis.
- Author
-
Aragao A, Biemer J, Barkan GA, and Pambuccian SE
- Subjects
- Biopsy, Fine-Needle, Female, Humans, Male, Middle Aged, Papanicolaou Test, Actinomyces isolation & purification, Actinomycosis, Cervicofacial microbiology, Actinomycosis, Cervicofacial pathology
- Published
- 2019
- Full Text
- View/download PDF
45. Touch imprint (TI) cytology of needle core biopsies (NCB) in pathology laboratories: A practice survey of participants in the College of American Pathologists (CAP) Non Gynecologic Cytopathology (NGC) Education Program.
- Author
-
Padmanabhan V, Barkan GA, Tabatabai L, Souers R, Nayar R, and Crothers BA
- Subjects
- Allied Health Personnel, Biopsy, Large-Core Needle, Humans, Laboratories, Surveys and Questionnaires, Cytodiagnosis methods, Pathology, Clinical methods, Practice Patterns, Physicians', Quality Assurance, Health Care
- Abstract
Background: Intra-procedural assessment of touch imprint (TI) cytology from needle core biopsies (NCB) is used to ensure sample adequacy and to provide immediate diagnosis in various settings. We aimed to survey laboratories for current practices on the use of cytology with NCB., Methods: A voluntary supplemental questionnaire including questions on demographics, personnel involved, sites, accessioning, and reporting was sent with the College of American Pathologists (CAP) 2015 Non gynecologic Cytopathology Education Program to survey practices of cytologic assessment of NCB., Results: Among 844 respondents, 403 (48%) performed cytologic assessment of NCB. Common body sites included lung (94%; 368/392), liver (87%; 340/ 392), and lymph nodes/spleen (77%; 303/392). Most of the time, a pathologist was present on-site 75% (295/393) for adequacy assessment which was usually verbally reported to the provider performing the procedure. Specimens were prepared by cytotechnologists (50%; 193 of 388) or pathologists (45%; 176 of 388) by touching the core to the slide (50%; 196 of 390) and rolling the core on the slide (45%; 177/390). Among the respondents, 19% said that cytotechnologists independently performed immediate assessment of TI of NCB. Most laboratories (69%; 264/384) evaluated air-dried slides with a modified Giemsa stain and rendered one TI/NCB combined report (87%, 334/385)., Conclusions: This is the first survey performed specifically to determine the practice of adequacy assessment of TI of NCB. Cytotechnologists are generally not performing adequacy assessment of TI without pathologist oversight. A single report is usually issued which includes the adequacy assessment as a part of the final report., (© 2018 Wiley Periodicals, Inc.)
- Published
- 2019
- Full Text
- View/download PDF
46. Negative predictive value and sensitivity of urine cytology prior to implementation of The Paris System for Reporting Urinary Cytology.
- Author
-
McIntire PJ, Khan R, Hussain H, Pambuccian SE, Wojcik EM, and Barkan GA
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Cohort Studies, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Sensitivity and Specificity, Urologic Neoplasms pathology, Young Adult, Urologic Neoplasms diagnosis
- Abstract
Background: Urinary tract cytology (UTCy) is used for screening urothelial carcinoma (UC) and it must have a high negative predictive value (NPV) to be an effective test. To the authors' knowledge, the literature regarding the NPV of UTCy provides little information regarding the risk of malignancy, especially for patients with high-grade urothelial carcinoma (HGUC)., Methods: Patients with negative UTCy specimens were identified in the pathology files at the study institution for the years 2012 through 2013. Cases were deemed true-negative cases if there was at least 1 subsequent negative specimen or negative clinical follow-up within 6 months of the index case. False-negative cases were defined as HGUC or carcinoma in situ by surgical biopsy and/or any UTCy with suspicious for HGUC or HGUC follow-up., Results: A total of 2614 UTCy specimens from 2089 patients were identified. There was a disease prevalence of 6.5%. There were 87 false-negative results for HGUC, which corresponded to an overall NPV of 96.7%. When categorized by clinical indication, hematuria resulted in the highest NPV of 99.5% followed by other indications (97.7%) and a history of UC (90.1%). When categorized by the specimen type, voided urine specimens were found to have the highest NPV of 98.7% followed by other indications (96.9%) and washing specimens (96.2%). Of the 717 patients with a history of UC, the NPV was lower for washing specimens (89.8%) than for voided urine specimens (96.2%). When including either low-grade urothelial carcinoma or HGUC as a positive follow-up, the NPV dropped to 93.3% from 96.7% (HGUC only). The sensitivity of the diagnostic category of atypical urothelial cells or higher was 93.0%., Conclusions: Overall, UTCy appears to have a good NPV and a high sensitivity for HGUC. The clinical indication had a greater impact on NPV compared with the specimen type., (© 2019 American Cancer Society.)
- Published
- 2019
- Full Text
- View/download PDF
47. The Use and Misuse of Statistical Methods in Cytopathology Studies: Review of 6 Journals.
- Author
-
Bahar B, Pambuccian SE, Barkan GA, and Akdas Y
- Subjects
- Cytodiagnosis methods, Cytodiagnosis statistics & numerical data, Data Interpretation, Statistical, Diagnostic Errors prevention & control, Diagnostic Errors statistics & numerical data, Humans, Biostatistics methods, Cytodiagnosis standards
- Abstract
Background: The misuse of statistical methods in diagnostic accuracy studies has been criticized in many publications., Objective: To assess the use and misuse of statistical methods in medical journal articles., Methods: We reviewed 141 original articles from 6 cytopathology journals published in 2014., Results: In total, 16 articles used no descriptive statistics and 66 articles used no inferential statistics. Also, 82 articles did not report using any tests for diagnostic accuracy. The most commonly adopted statistical measure for diagnostic accuracy was sensitivity, followed by specificity. The most common inferential statistical methods were χ2 testing, the Fisher exact test, and the Cohen kappa coefficient, respectively. Only 78 articles were free of statistical errors. "No statistics were used although statistical methods were required" was the most common type of error, followed by "failure to select proper statistical methods.", Conclusion: Our assessment of use of statistical methods in this subsection of pathology demonstrated a need for improvement.
- Published
- 2019
- Full Text
- View/download PDF
48. Unusual BK polyomavirus-associated urologic malignancies in renal transplant recipients: Report of two cases and review of the literature.
- Author
-
Odetola OE, Isaila B, Pambuccian SE, and Barkan GA
- Subjects
- Adult, Aged, Carcinoma etiology, Carcinoma virology, Cytodiagnosis methods, Humans, Kidney virology, Kidney Transplantation methods, Male, Polyomavirus Infections virology, Transplant Recipients, BK Virus pathogenicity, Polyomavirus Infections complications, Urologic Neoplasms etiology, Urologic Neoplasms virology
- Abstract
Renal transplant recipients are at increased risk of developing urologic malignancies, some of which are associated with prolonged BK virus infection. We report two cases of BK virus-associated carcinoma with variant morphological patterns (clear cell adenocarcinoma of the bladder and micropapillary urothelial carcinoma of the pelvicaliceal system) arising in the urinary tract of renal transplant recipients. In both cases, the diagnosis was initially established on cytologic specimens: on urine cytology in one patient and on fine needle aspiration of an inguinal lymph node in the other patient. The unusual cytologic features of both cases (multiple morphologies in one patient and micropapillary pattern in the other), co-occurrence of decoy cells in the urine of one patient and the occurrence of these tumors in renal transplant recipients raised the possibility of BK polyomavirus-associated malignancy and led to confirmatory SV40 immunostains that were positive. These cases expand the morphologic variants of BK virus-associated urologic malignancies diagnosed in solid organ transplant patients. While differentiating BK virus-infected cells from malignant cells in urine cytology specimens is a diagnostic challenge, greater awareness of their possible co-existence is vital, as this could be the only chance for an early diagnosis., (© 2018 Wiley Periodicals, Inc.)
- Published
- 2018
- Full Text
- View/download PDF
49. Prognostic pathological factors in radical cystectomy after neoadjuvant chemotherapy.
- Author
-
Brimo F, Downes MR, Jamaspishvili T, Berman D, Barkan GA, Athanazio D, Abro S, Visram K, Yilmaz A, Solanki S, Hahn E, Siemens R, Kassouf W, and Trpkov K
- Subjects
- Adult, Aged, Aged, 80 and over, Carcinoma, Transitional Cell mortality, Chemoradiotherapy, Adjuvant methods, Chemoradiotherapy, Adjuvant mortality, Cystectomy mortality, Disease-Free Survival, Female, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Neoadjuvant Therapy methods, Neoadjuvant Therapy mortality, Prognosis, Treatment Outcome, Urinary Bladder Neoplasms mortality, Carcinoma, Transitional Cell pathology, Carcinoma, Transitional Cell therapy, Urinary Bladder Neoplasms pathology, Urinary Bladder Neoplasms therapy
- Abstract
Aims: We undertook a systematic evaluation of the prognostic value of numerous histological factors in 165 radical cystectomies (RCs) of patients with invasive urothelial carcinoma (UC) who underwent surgery after neoadjuvant chemotherapy (NAC)., Methods and Results: Tumour regression grade (TRG) and therapy-related stromal and epithelial changes were also recorded. Locally advanced disease (≥pT2 and/or pN+) was present in 64% of patients, 22% had no evidence of residual carcinoma (pT0 + pN0), and 28% had no evidence of residual muscle-invasive carcinoma (≤pT1 + N0). TRG1, TRG2 and TRG3 were found in 32%, 15% and 50% of patients, respectively. Histological variants of UC were reported in 25% of cases. The most common therapy-related stromal change was fibroblastic reaction (78%), and the most common epithelial change in residual UC was smudgy and poorly preserved chromatin (28%). Prominent stromal and epithelial changes were noted in 41% and 5% of RCs, respectively. Progression was found in 45% of patients, and cancer-related deaths occurred in 30%. Multivariate analysis showed that the only independent prognostic parameters for progression were T stage, N stage, lymphovascular invasion, and margin status. Similarly, only T stage, N stage and margin status correlated with cancer-related deaths. Neither TRG nor any of the stromal-related or epithelial-related variables correlated with outcome., Conclusions: We confirm that the traditional and routinely reported histological parameters in RC post-NAC remain the most powerful prognosticators of disease course. The significance of TRG in the bladder remains unconfirmed., (© 2018 John Wiley & Sons Ltd.)
- Published
- 2018
- Full Text
- View/download PDF
50. Atypically presenting kaposiform hemangioendothelioma of the knee: ultrasound findings.
- Author
-
Erdem Toslak I, Stegman M, Reiter MP, Barkan GA, Borys D, and Lim-Dunham JE
- Subjects
- Child, Preschool, Diagnosis, Differential, Female, Hemangioendothelioma pathology, Hemangioendothelioma surgery, Humans, Kasabach-Merritt Syndrome pathology, Kasabach-Merritt Syndrome surgery, Knee, Sarcoma, Kaposi pathology, Sarcoma, Kaposi surgery, Vascular Neoplasms pathology, Vascular Neoplasms surgery, Hemangioendothelioma diagnostic imaging, Kasabach-Merritt Syndrome diagnostic imaging, Sarcoma, Kaposi diagnostic imaging, Vascular Neoplasms diagnostic imaging
- Abstract
Kaposiform hemangioendothelioma (KHE) is a rare vascular tumor of early childhood and infancy. Kasabach-Merritt phenomenon, a common complication of KHE, is characterized by life-threatening thrombocytopenia, hemolytic anemia, and consumption coagulopathy. There may be atypical cases that do not present with Kasabach-Merritt phenomenon and do have atypical imaging findings. Knowledge of atypical imaging features may assist radiologists in identifying KHE. In this report, we present a 4-year-old case of KHE with atypical ultrasound findings.
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.